Covidien (COV: Quote), a global provider of healthcare products, announced it has obtained 510(k) clearance from the U.S. Food and Drug Administration for the iDrive Ultra powered stapling system. The iDrive Ultra system is the second offering in Covidien's line of powered stapling devices and the first that is compatible with the company's entire portfolio of Endo GIA reloads with Tri-Staple technology for use in laparoscopic and open surgical procedures.
The company said the new stapling system is the only fully powered, reusable, battery-operated endoscopic surgical stapler in the world. The system will be available In the U.S. beginning in the fourth quarter of 2012.
Click here to receive FREE breaking news email alerts for Covidien Plc and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org